HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Domenico Gabrielli Selected Research

Warfarin (Coumadin)

3/2021Gastroprotection in patients on antiplatelet and/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO).
3/2020[ANMCO/AIGO Intersocietary consensus document: Gastroprotection in patients receiving antiplatelet and/or anticoagulant drugs].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Domenico Gabrielli Research Topics

Disease

33Heart Failure
04/2024 - 07/2009
17Atrial Fibrillation
01/2024 - 05/2012
16Hemorrhage
01/2024 - 05/2018
13Cardiovascular Diseases (Cardiovascular Disease)
04/2024 - 08/2020
13Acute Coronary Syndrome
01/2023 - 05/2018
10Neoplasms (Cancer)
05/2024 - 01/2021
10Myocardial Infarction
01/2024 - 11/2019
10Thrombosis (Thrombus)
06/2023 - 05/2018
9Stroke (Strokes)
01/2024 - 01/2020
9Coronary Artery Disease (Coronary Atherosclerosis)
12/2023 - 05/2016
9COVID-19
02/2022 - 08/2020
8Chronic Renal Insufficiency
01/2024 - 01/2021
7Atherosclerosis
01/2024 - 01/2020
6Venous Thromboembolism
01/2024 - 11/2019
6Type 2 Diabetes Mellitus (MODY)
04/2023 - 04/2021
5Hypercholesterolemia
07/2023 - 01/2021
4Cardiotoxicity
04/2024 - 01/2021
4Myocarditis (Carditis)
05/2023 - 12/2020
4Infections
05/2023 - 03/2020
3Cardiomyopathies (Cardiomyopathy)
04/2024 - 02/2023
3Thromboembolism
12/2023 - 12/2021
3Coronary Disease (Coronary Heart Disease)
11/2023 - 03/2023
3Dyslipidemias (Dyslipidemia)
08/2023 - 10/2020
3Inflammation (Inflammations)
06/2023 - 01/2022
3Cardiac Sudden Death (Sudden Cardiac Arrest)
05/2023 - 07/2015
3Ventricular Tachycardia
05/2023 - 07/2015
2Heart Valve Diseases (Valvular Heart Disease)
01/2024 - 03/2019
2Hypertriglyceridemia
12/2023 - 07/2019
2Fever (Fevers)
10/2023 - 04/2018
2Cardiac Arrhythmias (Arrythmia)
05/2023 - 05/2023
2Pulmonary Embolism
04/2023 - 08/2020
2Left Ventricular Dysfunction
01/2023 - 01/2022
2Substance-Related Disorders (Drug Abuse)
01/2023 - 06/2022
2Peripheral Arterial Disease
12/2022 - 11/2019
2Heart Diseases (Heart Disease)
10/2022 - 10/2019
2Chest Pain (Chest Pains)
06/2022 - 04/2018
2Thrombocytopenia (Thrombopenia)
02/2022 - 12/2021
2Cerebrovascular Disorders (Cerebrovascular Occlusion)
03/2021 - 03/2020
2Ulcer
03/2021 - 03/2020
1Sarcopenia
04/2024
1Second Primary Neoplasms (Neoplasms, Second)
04/2024

Drug/Important Bio-Agent (IBA)

17AnticoagulantsIBA
05/2024 - 01/2019
10Glucose (Dextrose)FDA LinkGeneric
03/2023 - 04/2021
8oxidized low density lipoproteinIBA
12/2023 - 07/2019
8Sodium-Glucose Transport ProteinsIBA
05/2023 - 05/2022
6LDL CholesterolIBA
05/2023 - 07/2019
6LipidsIBA
03/2023 - 07/2019
6SodiumIBA
10/2022 - 04/2021
5Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
12/2022 - 05/2018
5SymportersIBA
10/2022 - 08/2021
5Biomarkers (Surrogate Marker)IBA
10/2021 - 01/2021
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2023 - 07/2019
4dapagliflozinIBA
01/2023 - 08/2021
4Sodium-Glucose Transporter 2 InhibitorsIBA
01/2023 - 04/2021
4sacubitril and valsartan sodium hydrate drug combinationIBA
04/2022 - 10/2018
42'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
12/2020 - 05/2018
3vericiguatIBA
04/2024 - 04/2023
3Vitamin KFDA Link
12/2023 - 01/2020
38- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA
06/2023 - 01/2021
3Proteins (Proteins, Gene)FDA Link
02/2023 - 12/2021
3RivaroxabanIBA
12/2022 - 03/2020
3empagliflozinIBA
05/2022 - 08/2021
3VaccinesIBA
02/2022 - 12/2021
3omega-Chloroacetophenone (Mace)IBA
01/2022 - 01/2021
3EnalaprilFDA LinkGeneric
10/2021 - 10/2018
3CholesterolIBA
04/2021 - 10/2020
2CytokinesIBA
04/2024 - 01/2022
2Lipoprotein(a)IBA
01/2024 - 12/2022
2Uric Acid (Urate)IBA
06/2023 - 01/2022
2AntibodiesIBA
02/2022 - 12/2021
2ReninIBA
01/2022 - 04/2021
2Angiotensin Receptors (Angiotensin II Receptor)IBA
10/2021 - 10/2018
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2021 - 01/2019
2Neprilysin (Neutral Endopeptidase)IBA
10/2021 - 10/2018
2CanagliflozinIBA
08/2021 - 08/2021
2ertugliflozinIBA
08/2021 - 08/2021
2edoxabanIBA
03/2021 - 03/2020
2Purinergic P2Y Receptor AntagonistsIBA
03/2021 - 03/2020
2DabigatranFDA Link
03/2021 - 03/2020
2Proton Pump InhibitorsIBA
03/2021 - 03/2020
2Warfarin (Coumadin)FDA LinkGeneric
03/2021 - 03/2020
2SteroidsIBA
03/2021 - 03/2020
2trans-crotonin (CTN)IBA
01/2021 - 01/2020
2PCSK9 InhibitorsIBA
01/2020 - 07/2019
1AnthracyclinesIBA
04/2024
1ChemokinesIBA
04/2024
1Guanylate Cyclase (Guanylyl Cyclase)IBA
04/2024
1ElectrolytesIBA
01/2024

Therapy/Procedure

43Therapeutics
05/2024 - 07/2009
15Percutaneous Coronary Intervention
01/2023 - 05/2018
8Stents
05/2022 - 05/2018
4Defibrillators (Defibrillator)
11/2023 - 07/2015
4Secondary Prevention
01/2023 - 07/2019
3Catheters
05/2023 - 01/2023
3Heart-Assist Devices
05/2022 - 01/2022
2Continuity of Patient Care
01/2023 - 10/2019
2Heart Transplantation (Grafting, Heart)
05/2022 - 12/2020
2Inappropriate Prescribing
05/2022 - 12/2021
2Aftercare (After-Treatment)
10/2021 - 08/2021
1Telerehabilitation
04/2024